RDNT

Business Context and Reporting Period

Company: Radnet, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: Radnet operates 155 diagnostic imaging facilities across seven states, primarily in California, the Mid-Atlantic, Florida, Kansas, and New York. Services include MRI, CT, PET, nuclear medicine, mammography, and X-ray. The company operates as a single segment and relies heavily on third-party financing due to the capital-intensive nature of the industry.

Key Financial Metrics

Note: Total Debt calculated as sum of Notes Payable ($424,852), Obligations under Capital Leases ($39,048), and Line of Credit ($12,379) as of March 31, 2008.

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased 8.4% to $114.7 million, driven by higher procedure volumes at existing centers and the addition of new facilities.
• Operating Expenses: Increased 8.0% to $108.0 million. Salaries and professional fees rose 9.0% due to staffing for new centers. Stock-based compensation decreased significantly ($1.8 million drop) due to the absence of warrant vesting accelerations seen in the prior year.
• Bad Debt Provision: Decreased 14.1% to $6.5 million (5.7% of revenue) due to improved collection performance and billing system implementation.
• Interest Expense: Increased 25.4% to $13.6 million, attributed to higher debt levels ($60M increase in Term Loans) and $951,000 in realized losses on fair value hedges.
• Cash Flow: Operating cash flow turned negative ($2.7M outflow) compared to a $9.0M inflow in Q1 2007, primarily due to a $14.2M increase in accounts receivable. Investing outflows surged to $24.9M due to facility acquisitions and equipment purchases.

Guidance, Outlook, and Risks

• Capital Resources: On February 22, 2008, Radnet secured a second incremental $35 million facility from GE Commercial Finance. This increased the Applicable LIBOR Margin to 4.25% for the revolving facility and 9.0% for the second lien term loan. Management believes current cash and financing are sufficient to meet obligations for the next 12 months.
• Acquisitions: The company acquired The Rolling Oaks Imaging Group ($6.0M cash) and Papastavros Associates Medical Imaging ($9.0M cash) in Q1 2008. Additionally, on April 15, 2008 (subsequent event), Radnet completed the purchase of five Los Angeles-area centers from InSight Health Corp.
• Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2008, citing material weaknesses in the financial statement close process and entity-level controls. Remediation efforts include forming a Revenue Committee and assigning additional resources to fixed asset recording.
• Risks: The company faces risks related to third-party reimbursement rates, regulatory changes, and the ability to generate sufficient cash flow to service high debt levels. Legal proceedings regarding the sale of Duluth assets were resolved in Radnet's favor in May 2008.

Investor Verification Checklist

• Debt Servicing: Verify the company's ability to service approximately $449 million in debt given the recent increase in interest margins and negative operating cash flow.
• Internal Controls: Monitor the remediation of material weaknesses in financial reporting controls identified in Item 4.
• Accounts Receivable: Review the $14.2M increase in accounts receivable and the effectiveness of the new Revenue Committee in managing collections.
• Acquisition Integration: Assess the financial performance and integration of the Rolling Oaks and Papastavros acquisitions, as well as the subsequent InSight Health Corp. centers.
• Interest Rate Exposure: Evaluate the impact of the increased LIBOR margins on future interest expenses, despite the use of interest rate swaps on $270 million of debt.